Liposomal delivery for enhanced absorption starting in the mouth
The semaglutide variant for weight management, Wegovy, raked in $3.32 billion, while sales of the oral type 2 diabetes version of the drug, Rybelsus, hit $2.72 billion
Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan
Many people face this same challenge, and the good news is that there's a sustainable way to maintain the benefits of these medications while gradually reducing your dependence on GLP-1 drugs - even if you feel like you'd tried everything before going on the drugs
The bottom line: your daily food choices may help encourage your body's natural GLP-1 activitywithout the need for medication
To view digital features for this article, go to Introduction Diabetes care is evolving towards the personalized medicine approach, moving beyond the basic assumption that diabetes is solely a consequence of -cell dysfunction in a single hormone, insulin [1,2,3,4]